These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2994681)

  • 1. Effect of probenecid on the disposition of captopril and captopril dimer in the rat.
    Drummer OH; Thompson J; Hooper R; Jarrott B
    Biochem Pharmacol; 1985 Sep; 34(18):3347-51. PubMed ID: 2994681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril disulfide conjugates may act as prodrugs: disposition of the disulfide dimer of captopril in the rat.
    Drummer OH; Jarrott B
    Biochem Pharmacol; 1984 Nov; 33(22):3567-71. PubMed ID: 6095854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal handling of captopril: effect of probenecid.
    Sinhvi SM; Duchin KL; Willard DA; McKinstry DN; Migdalof BH
    Clin Pharmacol Ther; 1982 Aug; 32(2):182-9. PubMed ID: 7047044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined gas chromatographic-mass spectrometric procedure for the measurement of captopril and sulfur-conjugated metabolites of captopril in plasma and urine.
    Drummer OH; Jarrott B; Louis WJ
    J Chromatogr; 1984 Jan; 305(1):83-93. PubMed ID: 6368577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of captopril and its disulphide in biological fluids.
    Matsuki Y; Ito T; Fukuhara K; Nakamura T; Kimura M; Ono H
    J Chromatogr; 1982 Apr; 239():585-94. PubMed ID: 7047545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril: pharmacology, metabolism and disposition.
    Migdalof BH; Antonaccio MJ; McKinstry DN; Singhvi SM; Lan SJ; Egli P; Kripalani KJ
    Drug Metab Rev; 1984; 15(4):841-69. PubMed ID: 6437780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of captopril in normal subjects.
    Kripalani KJ; McKinstry DN; Singhvi SM; Willard DA; Vukovich RA; Migdalof BH
    Clin Pharmacol Ther; 1980 May; 27(5):636-41. PubMed ID: 6989546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of captopril and its mixed disulphides in plasma and urine by high-performance liquid chromatography.
    Hayashi K; Miyamoto M; Sekine Y
    J Chromatogr; 1985 Feb; 338(1):161-9. PubMed ID: 3894398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits.
    Chen X; Pitt BR; Moalli R; Gillis CN
    J Pharmacol Exp Ther; 1984 Jun; 229(3):649-53. PubMed ID: 6327968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients.
    Richer C; Giroux B; Plouin PF; Maarek B; Giudicelli JF
    Br J Clin Pharmacol; 1984 Mar; 17(3):243-50. PubMed ID: 6324834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of captopril in biological fluids by gas-liquid chromatography.
    Matsuki Y; Fukuhara K; Ito T; Ono H; Ohara N; Yui T; Nambara T
    J Chromatogr; 1980 Jan; 188(1):177-83. PubMed ID: 6991514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of blood pressure and angiotensin-converting enzyme activity to acute captopril administration in normotensive and hypertensive rats.
    Levens NR; Peach MJ; Vaughan ED; Weed WC; Carey RM
    Endocrinology; 1981 Feb; 108(2):536-44. PubMed ID: 6256155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure.
    Onoyama K; Hirakata H; Iseki K; Fujimi S; Omae T; Kobayashi M; Kawahara Y
    Hypertension; 1981; 3(4):456-9. PubMed ID: 7030952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of protein conjugate of desacetyl-alacepril and its effect on angiotensin converting enzyme in renal hypertensive rats.
    Matsumoto K; Nambu K; Fujii T; Takeyama K; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):52-4. PubMed ID: 3006711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination kinetics of captopril in patients with renal failure.
    Duchin KL; Pierides AM; Heald A; Singhvi SM; Rommel AJ
    Kidney Int; 1984 Jun; 25(6):942-7. PubMed ID: 6381858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive inhibitor binding assay (IBA) of captopril and other inhibitors of angiotensin converting enzyme.
    Tikkanen FF; Grönhagen-Riska C
    Scand J Urol Nephrol Suppl; 1984; 79():13-6. PubMed ID: 6089313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
    Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric and intestinal absorption of captopril in acutely and chronically treated rats: comparison with salicylic acid.
    Worland PJ; Drummer OH; Jarrott B
    J Pharm Sci; 1984 Dec; 73(12):1755-8. PubMed ID: 6396399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous kinetic modelling of plasma levels and urinary excretion of salicyluric acid, and the influence of probenecid.
    Hekman P; van Ginneken CA
    Eur J Drug Metab Pharmacokinet; 1983; 8(3):239-49. PubMed ID: 6653616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.